dismiss

Visit DOTmed at AORN Denver, Booth #2427, March 15-17 / Video Interviews

Other Headlines

The DOTmed 100 company has a long tradition in medical technology.
Joint venture agreement with Japan's M-Cast, Inc., a subsidiary of leasing giant Mitsubishi UFJ Leasing and Finance.
RAND study confirms patients getting inaccurate information on physicians.
Matrox Xenia Pro display controller boards now available with WIDE Power-Series diagnostic displays.
New KLAS report looks at smart pump adoption trends and the customer satisfaction gap among some products.

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More Industry Headlines

Health Care Vote May Come This Weekend Weekend vote is a possibility according to House Majority Leader.

ECR Video Profile: Dunlee, Philips Healthcare David Kuehn of Dunlee presents the company's two new products.

Imaging 100 Preview: The Importance of Banding Together During Health Care Reform Imaging 100 speakers will focus on important health care reform issues.

Congressmen Introduce Bill for Electronic Health Record Interoperability While reform inches along, other legislation progresses.

ECR 2010 Video Profile: Barco DOTmed News stopped by Barco's booth to check out their upcoming medical tablets (developed by FIMI, Barco's recent acquisition) and their latest clinical displays that bring DICOM-compliant viewing outside of the radiologist's office.

CCHIT Comments on ONC's EHR Interim Final Rule The certification organization for electronic health records in the U.S. points out problems in vagueness, complexity of criteria. Also, get a DOTmed exclusive update on CCHIT's testing status.

MEDCAC to Meet on Prostate Determination CMS to review coverage decisions about radiation therapy April 21.

Health Care Reform Round-Up: More Maneuvers May Be Needed for Passage House leaders said to be considering "self-executing" rule for Senate bill passage.

Michigan Legislature Sends Device Re-Use Bill to Governor Bill would prohibit reusing single-use devices.

GAO Asked to Review Quality, Safety, in Long-Term Care Hospitals Senators request inquiry, company defends record.

GE in the news

Shareholders Sue GE Over Dividend Cut

by Lynn Shapiro, Writer
GE's stock fell about 16 percent Wednesday, as news that shareholders are suing GE's chief executive Jeff Immelt and other top officials added to the company's troubles.

"The law firm of Harwood Feffer LLP filed a class action lawsuit on March 3, 2009 on behalf of purchasers of the common stock of General Electric Company during the period January 23, 2009 through February 27, 2009," the plantiffs' lawyers announced.

Story Continues Below Advertisement
DOTmed Text Ad

Largest Buyer & Seller of Pre Owned Diagnostic Imaging Equipment in the USA

Bay Shore offers free up-to-date market valuations & quotations for diagnostic imaging equipment on sales, purchases, or replacements. Call our MRI specialist John Kollegger today toll free 800.471.1189 ext 120


"The complaint alleges that on January 23, 2009, the company's chairman and CEO, Jeffrey Immelt, stated unequivocally that GE would maintain its quarterly $.31 per share dividend, having sufficient cash on hand and cash flow to achieve that goal.

"Then on February 27, 2009, GE suddenly announced it was cutting the dividend to $.10 per share. On the first trading day after the dividend reduction announcement, GE shares fell from $8.51 per share the previous trading day to close at $7.60 per share. The shares have continued to plummet, currently trading at $6.30 per share, an almost 30 percent plunge," the lawsuit says.

The complaint goes on to say that during the same period, Immelt sold over 52,000 shares of GE stock at $11.10 per share and other officers of the company sold over 380,000 shares at that same price.

"Mr. Immelt then repurchased 50,000 shares after the announcement at between $7.51 and $8.30 per share. As a result, Mr. Immelt and the other officers violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by issuing false and misleading statements or knowingly or recklessly failing to know of those statements, sold GE shares at inflated prices based on those statements," the plaintiff's lawyers said.

Immelt and GE Capital's chief, Michael A. Neal, said they bought stock on Monday to show their confidence in the company. Meanwhile, analysts following GE say that GE's board should vote to spin off the financial business, so GE's industrial businesses will be allowed to thrive. GE Capital is dragging the company down, so that its shares are trading at just 8.5 times estimated earnings, not a fair valuation for GE, considering its industrial units are worth far more than that.

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Printable Story
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2010 DOTmed.com, Inc.
ALL RIGHTS RESERVED